Related Experiment Video
Updated: Aug 11, 2026
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Osteoblast dysfunction in male idiopathic osteoporosis
1Endocrine and Diabetes Unit, Department of Molecular Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm S-171 76, Sweden. Ylva.Pernow@ki.se
Calcified Tissue International
|February 10, 2006
Summary
Idiopathic osteoporosis in men involves osteoblast dysfunction, leading to reduced osteocalcin production and increased factors that stimulate bone breakdown. This cellular imbalance causes negative bone turnover and osteoporosis.
Area of Science:
- Cellular and Molecular Biology
- Endocrinology
- Bone Metabolism
Background:
- The causes of primary osteoporosis in younger and middle-aged men remain largely unknown.
- Osteoblast dysfunction is a potential contributor to osteoporosis, but specific cellular mechanisms in men are not well understood.
Purpose of the Study:
- To investigate osteoblast function in men with idiopathic osteoporosis compared to healthy controls.
- To identify specific cellular defects in osteoblasts that may contribute to bone loss in men.
Main Methods:
- Osteoblasts were isolated from bone biopsies of men with idiopathic osteoporosis and age-matched controls with osteoarthrosis.
- Assessed vitamin D-stimulated osteocalcin production, cytokine production (M-CSF, IL-6), and cell proliferation ((3)H-thymidine incorporation).
- Measured Parathyroid hormone-related peptide (PTHrP) mRNA levels and PTHrP-stimulated proliferation.
Main Results:
- Osteoblasts from osteoporotic men showed reduced vitamin D-stimulated osteocalcin production.
- Increased production of macrophage colony-stimulating factor (M-CSF) and interleukin-6 (IL-6) was observed in osteoporotic osteoblasts.
- Osteoporotic osteoblasts exhibited higher basal PTHrP mRNA levels and impaired PTHrP-stimulated proliferation.
Conclusions:
- Men with idiopathic osteoporosis exhibit osteoblast dysfunction characterized by decreased osteocalcin synthesis and increased production of osteoclast-activating factors.
- This cellular dysfunction suggests a catabolic metabolic state contributing to negative bone turnover and osteoporosis.
- Further research is needed to determine the underlying causes of this cellular dysfunction.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:02What is the Skeletal System?
Overview
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:22The Functions of the Skeletal System
The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...